Results 201 to 210 of about 21,622 (232)
Some of the next articles are maybe not open access.

IPSS-M(r): A Reduced Feature Representation of IPSS-M for Clinical Application

Blood
Background: The Molecular International Prognostic Scoring System (IPSS-M) is the most recent and comprehensive risk stratification scheme for myelodysplastic neoplasms. In total, IPSS-M requires 41 features (mutational data, cytogenetics, and clinical parameters) that are divided into main effect variables and ...
Vikram Dhillon   +6 more
openaire   +1 more source

Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine

Blood, 2016
Background The international prognostic risk score (IPSS) is a validated tool in the prognosis of myelodysplastic syndromes (MDS). Patients who fall into the Int-2 and High categories of the IPSS qualify for treatment with 5-azacitidine, a hypomethylating agent that has been shown to provide a survival advantage with these prognostic ...
Roman M Shapiro, Alejandro Lazo-Langner
openaire   +1 more source

Management der IPSS-Erbringung - IPSS-Execution System mit integrierter Performance-Messmethode

2017
Industrielle Produkt-Service Systeme (IPSS) bestehen aus Sach- und Dienstleistungsanteilen sowie aus industriellen Produkt-Service Modulen (IPSM). Alle Anteile mussen integriert geplant, entwickelt und erbracht werden. Das Management des Anbieternetzwerks und die Planung und Steuerung der Erbringung sind aufwendige Aufgaben, denen sich ein IPSS ...
Thomas Dorka   +2 more
openaire   +1 more source

Are IPSS-R and IPSS Cytogenetic Risk Stratification Informative At the Time of Allogeneic Hematopoietic Cell Transplantation?

Blood, 2012
Abstract Abstract 1400 Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell disorders. Cytogenetic aberrations are one of the main elements of risk stratification among published scoring systems including the International Prognostic Scoring System (IPSS) or its recent revision (R-IPSS).
Zohar Sachs   +7 more
openaire   +1 more source

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Blood, 2013
Abstract Background International Prognostic Scoring System (IPSS) is commonly used to distinguish various subgroups of myelodysplastic syndrome (MDS) patients with different prognosis and to make a therapeutic decision.
Joon Ho Moon   +13 more
openaire   +1 more source

Bewertung von IPSS-Erbringungsprozessen

2017
Hoch dynamische, globale Markte erfordern kundenindividuelle Gesamtlosungen anstatt traditioneller, rein technologiebasierter Geschaftsmodelle. Industrielle Produkt-Service Systeme (IPSS) stellen diese innovativen Problemlosungen dar. Zentraler Bestandteil von IPSS sind Erbringungsprozesse, die zusammen mit Sachleistungen einen kundenspezifischen ...
Arne Viertelhausen, Horst Meier
openaire   +1 more source

IPSS: Prague, Czech Republic

2007
Abstract In the fifth and sixth centuries, the Slavs migrated into Prague, founding Prague Castle, which became a cultural and spiritual center. Prague was the capital of Bohemia from the ninth century on. In the 14th century under King Charles IV, it became the capital of the “Holy Empire of the German Nation,” boasting the first ...
Ctirad Skoda   +2 more
openaire   +1 more source

THE NEW MOLECULAR IPSS

Leukemia Research, 2023
openaire   +1 more source

IPSS-m outperforms IPSS-R in younger adults with Myelodysplastic Syndromes: A retrospective age-stratified analysis

Blood
Abstract Introduction Myelodysplastic syndromes (MDS) predominantly affect older adults, with a median age at diagnosis over 70 years, and fewer than 10% of cases occurring before age 50.
Jinjun Yang, Ya Zhang, Yu Wu
openaire   +1 more source

Home - About - Disclaimer - Privacy